Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9571-9585
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9571
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9571
Figure 1 Overall (A) and recurrence-free (B) survival rates of diabetes mellitus and non-diabetes mellitus patients with hepatocellular carcinoma.
DM: Diabetes mellitus.
Figure 2 Overall survival rates of diabetes mellitus and non-diabetes mellitus hepatocellular carcinoma patients with presence of vascular invasion (A), age > 50 years (B), alanine aminotransferase levels > 40, ≤ 80 IU/L (C).
ALT: Alanine aminotransferase; DM: Diabetes mellitus.
Figure 3 Recurrence-free survival rates of diabetes mellitus and non-diabetes mellitus hepatocellular carcinoma patients with vascular invasion and (A), age > 50 years (B), alanine aminotransferase levels between 40 and 80 IU/L (C).
ALT: Alanine aminotransferase; DM: Diabetes mellitus.
- Citation: Zhang Q, Deng YL, Liu C, Huang LH, Shang L, Chen XG, Wang LT, Du JZ, Wang Y, Wang PX, Zhang H, Shen ZY. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol 2016; 22(43): 9571-9585
- URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9571.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9571